iShares Trust - iShares Biotechnology ETF
GB ˙ LSE ˙ US4642875565
131,05 $ ↓ -0,77 (-0,58%)
2023-12-18
DEL PRIS
SecurityGB:0JGB / iShares Trust - iShares Biotechnology ETF
InstitutionSound View Wealth Advisors Group, LLC
Latest Disclosed Ownership5,666 shares
Latest Disclosed Value $ 956,788
Sound View Wealth Advisors Group, LLC reports 0.81% decrease in ownership of 0JGB / iShares Trust - iShares Biotechnology ETF

On May 6, 2026 - Sound View Wealth Advisors Group, LLC filed a 13F-HR form disclosing ownership of 5,666 shares of iShares Trust - iShares Biotechnology ETF (GB:0JGB) valued at $956,788 USD as of March 31, 2026. The entity filed a previous 13F-HR on January 8, 2026 disclosing 5,712 shares of iShares Trust - iShares Biotechnology ETF. This represents a change in shares of -0.81% during the quarter. The current value of the position is $742,529 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-06 2026-03-31 13F ISHARES TR ISHARES BIOTECH 464287556 5,666 -46 -0.81 957 -0.73 0.0651
2026-01-08 2025-12-31 13F ISHARES TR ISHARES BIOTECH 464287556 5,712 -567 -9.03 964 6.29 0.0647
2025-11-10 2025-09-30 13F ISHARES TR ISHARES BIOTECH 464287556 6,279 -114 -1.78 906 12.13 0.0623
2025-08-07 2025-06-30 13F ISHARES TR ISHARES BIOTECH 464287556 6,393 -80 -1.24 809 -2.30 0.0598
2025-05-08 2025-03-31 13F ISHARES TR ISHARES BIOTECH 464287556 6,473 -324 -4.77 828 -7.91 0.0679
2025-02-07 2024-12-31 13F ISHARES TR ISHARES BIOTECH 464287556 6,797 335 5.18 899 -4.47 0.0724
2024-11-12 2024-09-30 13F ISHARES TR ISHARES BIOTECH 464287556 6,462 820 14.53 941 21.45 0.0768
2024-08-05 2024-06-30 13F ISHARES TR ISHARES BIOTECH 464287556 5,642 -62 -1.09 774 -1.02 0.0798
2024-05-09 2024-03-31 13F ISHARES TR ISHARES BIOTECH 464287556 5,704 -867 -13.19 783 -12.33 0.0834
2024-02-08 2023-12-31 13F ISHARES TR ISHARES BIOTECH 464287556 6,571 798 13.82 893 26.52 0.0985
2023-11-07 2023-09-30 13F ISHARES TR ISHARES BIOTECH 464287556 5,773 -56 -0.96 706 -4.73 0.0878
2023-08-08 2023-06-30 13F ISHARES TR ISHARES BIOTECH 464287556 5,829 -176 -2.93 740 -4.52 0.0970
2023-05-12 2023-03-31 13F ISHARES TR ISHARES BIOTECH 464287556 6,005 -566 -8.61 776 -13.12 0.1064
2024-02-13 2022-12-31 13F/A-1 ISHARES TR ISHARES BIOTECH 464287556 6,571 2,567 64.11 893 90.60 0.0985
2023-02-08 2022-12-31 13F ISHARES TR ISHARES BIOTECH 464287556 3,959 -45 520 0.1099
2022-11-08 2022-09-30 13F ISHARES TR ISHARES BIOTECH 464287556 4,004 -19 -0.47 468 -1.06 0.1050
2022-08-05 2022-06-30 13F ISHARES TR ISHARES BIOTECH 464287556 4,023 65 1.64 473 -8.33 0.0990
2022-05-11 2022-03-31 13F ISHARES TR ISHARES BIOTECH 464287556 3,958 1,465 58.76 516 35.43 0.0981
2022-01-20 2021-12-31 13F ISHARES TR ISHARES BIOTECH 464287556 2,493 19 0.77 381 -4.75 0.0720
2021-10-21 2021-09-30 13F ISHARES TR ISHARES BIOTECH 464287556 2,474 55 2.27 400 1.01 0.0835
2021-07-21 2021-06-30 13F ISHARES TR ISHARES BIOTECH 464287556 2,419 27 1.13 396 10.00 0.0832
2021-04-28 2021-03-31 13F ISHARES TR NASDAQ BIOTECH 464287556 2,392 440 22.54 360 21.62 0.0838
2021-02-02 2020-12-31 13F ISHARES TR NASDAQ BIOTECH 464287556 1,952 -289 -12.90 296 -2.31 0.0723
2020-11-09 2020-09-30 13F ISHARES TR NASDAQ BIOTECH 464287556 2,241 12 0.54 303 -0.66 0.0798
2020-08-07 2020-06-30 13F ISHARES TR NASDAQ BIOTECH 464287556 2,229 -86 -3.71 305 22.49 0.0859
2020-05-12 2020-03-31 13F ISHARES TR NASDAQ BIOTECH 464287556 2,315 3 0.13 249 -10.75 0.0860
2020-01-27 2019-12-31 13F ISHARES TR NASDAQ BIOTECH 464287556 2,312 -259 -10.07 279 8.98 0.0787
2019-11-07 2019-09-30 13F ISHARES TR NASDAQ BIOTECH 464287556 2,571 -58 -2.21 256 -10.80 0.0763
2019-08-07 2019-06-30 13F ISHARES TR NASDAQ BIOTECH 464287556 2,629 2,629 287 0.0848
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.